Marketing/Promotional Initiatives by Pharmaceutical Companies – “Doctor’s  Perspective”

Marketing/Promotional Initiatives by Pharmaceutical Companies – “Doctor’s Perspective”

Mr. Nadiminti Rajesh Kumar

Contact

Dr. Sajid Alvi

Contact

Marketing/Promotional Initiatives by Pharmaceutical Companies – “Doctor’s Perspective”

Article Fingerprint

ReserarchID

PDDTMLV57O

Marketing/Promotional Initiatives by Pharmaceutical Companies – “Doctor’s Perspective” Banner

AI TAKEAWAY

Connecting with the Eternal Ground

References

10 Cites in Article

Reference Format

Stefan Balkanski,Ilkogetov (2019). E-Detailing: Keyways for Successful Implementation of Digital Technologies in the Pharmaceutical Marketing.
Saikat Banerjee,Sampada Dash (2011). Effectiveness of e-detailing as an innovative pharmaceutical marketing tool in emerging economies: Views of health care professionals of India.
Shrihari Sridhar,Murali Mantrala,Sönke Albers (2014). Pharmaceutical Detailing Elasticities: A Meta-Analysis.
Jean-Claude Andreani (2014). Digital marketing effects and synergy in IMC-insights from the pharmaceutical industry.
Ashok Panigrahi,Komal Aware,Akshay Patil (2018). Application of Integrated Marketing Communication in Pharmaceutical Industry.
Mithun Nandy,Dr. Pal (2016). Pharmaceutical Marketing & Product Promotion: A Paradigm Shift in Indian Pharmaceutical Industry (IPI).
Sridhar Narayanan,Puneet Manchanda (2009). Heterogeneous Learning and the Targeting of Marketing Communication for New Products.
Saikat Banerjee,Sampada Kumar,Dash (2011). Factors influencing scope and acceptability of E-detailing as a pharmaceutical marketing communication tool in emerging economies like India.
Brian Edwards,Sweta Chakraborty (2012). Risk Communication and the Pharmaceutical Industry.
Sridhar Narayanan,Puneet Manchanda,Pradeep Chintagunta (2005). Temporal Differences in the Role of Marketing Communication in New Product Categories.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Mr. Nadiminti Rajesh Kumar. 2020. \u201cMarketing/Promotional Initiatives by Pharmaceutical Companies – “Doctor’s Perspective”\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 20 (GJMR Volume 20 Issue B7).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 20 Issue B7

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-B Classification NLMC Code: QV 701

Submission ReceivedDecember 8, 2019
Peer Review Double Blind
Handling Editor
Accepted January 5, 2020
Published January 15, 2020

Version of record

v1.2

Issue date

October 19, 2020

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 2298

Total Downloads: 983

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]